CERO(Delisted)
CERo TherapeuticsยทNASDAQ
--
--(--)
8.20 / 10
Outperform
Money flow excels (8.2/10) with 57.7% overall inflow. Large/Extra-large investors drive positive trends (62.5% inflow), while small/medium investors exit. No analyst ratings available.
Fund Flow Rating
Is money flowing into or out of CERO?
- CERO holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.20/10 (Outperform).
